NERI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 230
AS - Asia 105
EU - Europa 87
SA - Sud America 13
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 437
Nazione #
US - Stati Uniti d'America 225
SG - Singapore 96
IT - Italia 39
DE - Germania 17
GB - Regno Unito 13
BR - Brasile 11
FI - Finlandia 6
SE - Svezia 5
CA - Canada 4
HK - Hong Kong 4
AT - Austria 2
BD - Bangladesh 2
CL - Cile 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CN - Cina 1
CZ - Repubblica Ceca 1
EE - Estonia 1
IN - India 1
IQ - Iraq 1
MX - Messico 1
NL - Olanda 1
NO - Norvegia 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 437
Città #
Singapore 76
Chandler 50
Santa Clara 14
Chicago 13
Lawrence 13
London 13
Princeton 13
Milan 11
Munich 11
Naples 6
Ashburn 5
Turku 5
Hong Kong 4
New York 4
Assago 2
Boston 2
Brescia 2
Des Moines 2
Los Angeles 2
San Nicola Manfredi 2
Stockholm 2
São Paulo 2
Andover 1
Augusta 1
Bagé 1
Barueri 1
Basti 1
Boardman 1
Brooklyn 1
Charlotte 1
Council Bluffs 1
Dallas 1
Denver 1
Dhaka 1
Duhok 1
Greenville 1
Hanover 1
Helsinki 1
Houston 1
Ipiaú 1
Itabira 1
Jacareí 1
Johannesburg 1
Juiz de Fora 1
King City 1
Messina 1
Mexico City 1
Montreal 1
Mountain View 1
Norfolk 1
Norwalk 1
Novokuznetsk 1
Olomouc 1
Palermo 1
Parma 1
Passo Fundo 1
Pianopoli 1
Redmond 1
Richmond 1
Rio de Janeiro 1
San Francisco 1
San Mateo 1
Serrinha 1
Settingiano 1
Tallahassee 1
The Dalles 1
Torino 1
Wilmington 1
Totale 300
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 84
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 41
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 39
In Vitro Silencing of lncRNAs Using LNA GapmeRs 37
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network 35
Znf521 enhances mll‐af9‐dependent hematopoietic stem cell transformation in acute myeloid leukemias by altering the gene expression landscape† 33
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells 31
The non-coding RNA landscape of plasma cell dyscrasias 28
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 25
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 19
Dissecting the biological relevance and clinical impact of lncrna miat in multiple myeloma 18
The landscape of signaling pathways and proteasome inhibitors combinations in multiple myeloma 17
Epigenetic regulation of mitochondrial quality control genes in multiple myeloma: A sequenom massarray pilot investigation on hmcls 17
Genomic instability in multiple myeloma: A “non‐coding rna” perspective 16
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 13
Totale 453
Categoria #
all - tutte 5.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 1 0 0 0 2 0 0
2021/202237 0 0 0 4 0 0 10 2 7 7 7 0
2022/2023123 27 8 19 1 14 7 0 13 23 5 5 1
2023/202475 10 15 9 12 4 16 1 0 1 0 2 5
2024/2025199 24 3 7 13 12 38 8 9 7 3 29 46
2025/202614 14 0 0 0 0 0 0 0 0 0 0 0
Totale 453